Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink

BACKGROUND: Intensification of metformin monotherapy with additional glucose-lowering drugs is often required in patients with type 2 diabetes (T2D). This study evaluated changes in HbA1c and weight, as well as treatment persistence, associated with different second-line therapies used in UK clinica...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Med
Auteurs principaux: Wilding, John, Godec, Thomas, Khunti, Kamlesh, Pocock, Stuart, Fox, Robin, Smeeth, Liam, Clauson, Per, Fenici, Peter, Hammar, Niklas, Medina, Jesús
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047134/
https://ncbi.nlm.nih.gov/pubmed/30008267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1085-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires